Bayer-Schering Pharma

Pharmaceutical business formed when the German company Bayer bought Schering AG of Berlin in 2006 and merged it with its own pharmaceutical arm as Bayer Schering Pharma, since renamed Bayer HealthCare Pharmaceuticals and now the pharmaceuticals division of Bayer with its head office in Berlin and Leverkusen. Develops and sells prescription medicines in cardiology with rivaroxaban, oncology, ophthalmology with aflibercept, women's health and contraception and radiology contrast media, and runs research, clinical development and manufacturing worldwide.